| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |